Robert Booth PhD
Founder and Chairman, Virobay; Operating Partner, TPG
Robert Booth PhD
Founder and Chairman, Virobay; Operating Partner, TPG
Robert Booth was the driving force behind the creation of Virobay in 2006. Previously, he was Senior Vice President of Research & Development at Celera Genomics, responsible for integrating and leading Celera's therapeutic discovery and development activities with an R&D staff of about 300 people.
Robert also served in a series of executive positions at Roche for over 13 years, including Senior Vice President responsible for research and early development of inflammatory, viral, respiratory, and bone disease products.
Robert obtained his PhD in biochemistry from the University of London.
